Homodimere Proteinkonstrukte

European patent · EP2585107 · In force

Register entry

Publication number
EP2585107
Application number
EP11727190
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 24, 2011
Published
May 1, 2013
Granted
Oct 24, 2018
Protection ends at the latest
Jun 23, 2031
Next annual fee due
Jun 30, 2027
IPC classes
A61K 39/385 (2006.01)
C07K 19/00 (2006.01)
C07K 14/52 (2006.01)
C07K 16/44 (2006.01)
C07K 16/00 (2006.01)
A61P 35/00 (2006.01)
A61P 31/16 (2006.01)
Priority
US 358513 P 25.06.2010
EP 10167291 25.06.2010
PCT application
PCT/EP2011/060628 24.06.2011
PCT publication
WO2011/161244 29.12.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Aug 19, 2025

    Agent’s address changed

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 106, 8001 Zürich → Stolmár & Partner Intellectual Property GmbH, Bahnhofstrasse 11, 6210 Sursee

    Published in Swissreg on 19.08.2025

  3. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  5. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  6. Jan 24, 2023

    Transferred

    Owner
    Nykode Therapeutics AS, Gaustadalleen 21, 0349 Oslo, Norway → Nykode Therapeutics ASA, Gaustadalléen 21, 0349 Oslo, Norway

    Published in Swissreg on 24.01.2023

  7. Nov 9, 2022

    Address changed

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l, Rue du Cendrier 15, CP 1489, 1201 Genève → Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 106, 8001 Zürich

    Published in Swissreg on 09.11.2022

  8. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

3 earlier entries
  1. Jun 15, 2022

    Address changed

    Owner
    Vaccibody AS, Gaustadalleen 21, 0349 Oslo, Norway → Nykode Therapeutics AS, Gaustadalleen 21, 0349 Oslo, Norway

    Published in Swissreg on 15.06.2022

  2. Jan 24, 2019

    Agent entered

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l, Rue du Cendrier 15, CP 1489, 1201 Genève

    Published in Swissreg on 24.01.2019

  3. Oct 24, 2018

    Granted

    Published in Swissreg on 24.10.2018

Parties

Holder

Nykode Therapeutics ASA

Gaustadalléen 21, 0349 Oslo, NO

Agent

Stolmár & Partner Intellectual Property GmbH

Bahnhofstrasse 11, 6210 Sursee

Inventor

RUFFINI, Pier Adelchi

I-20141 Milano, IT

FREDRIKSEN, Agnete Brunsvik

N-2005 Rælingen, NO

BOGEN, Bjarne

N-1367 Snarøya, NO

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.